Log in

NYSE:VAPOVapotherm Stock Price, Forecast & News

+1.25 (+4.93 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $26.63
50-Day Range
MA: $22.26
52-Week Range
Now: $26.63
Volume536,207 shs
Average Volume485,708 shs
Market Capitalization$567.22 million
P/E RatioN/A
Dividend YieldN/A
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.14 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments



Sales & Book Value

Annual Sales$48.10 million
Book Value$1.94 per share


Net Income$-51,060,000.00


Market Cap$567.22 million
Next Earnings Date8/3/2020 (Estimated)
OptionableNot Optionable

Receive VAPO News and Ratings via Email

Sign-up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.

Vapotherm (NYSE:VAPO) Frequently Asked Questions

How has Vapotherm's stock been impacted by COVID-19 (Coronavirus)?

Vapotherm's stock was trading at $7.79 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VAPO shares have increased by 241.8% and is now trading at $26.63. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Vapotherm?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Vapotherm.

When is Vapotherm's next earnings date?

Vapotherm is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Vapotherm.

How were Vapotherm's earnings last quarter?

Vapotherm Inc (NYSE:VAPO) released its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.66) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.56) by $0.10. The business earned $19.12 million during the quarter, compared to the consensus estimate of $18.90 million. Vapotherm had a negative return on equity of 109.58% and a negative net margin of 94.57%. View Vapotherm's earnings history.

What guidance has Vapotherm issued on next quarter's earnings?

Vapotherm issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18.9-18.9 million, compared to the consensus revenue estimate of $13.61 million.

What price target have analysts set for VAPO?

3 analysts have issued 1-year price objectives for Vapotherm's stock. Their forecasts range from $30.00 to $32.00. On average, they anticipate Vapotherm's stock price to reach $31.00 in the next year. This suggests a possible upside of 16.4% from the stock's current price. View analysts' price targets for Vapotherm.

Has Vapotherm been receiving favorable news coverage?

Media headlines about VAPO stock have been trending somewhat positive on Saturday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vapotherm earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutVapotherm.

Who are some of Vapotherm's key competitors?

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Walt Disney (DIS), Inovio Pharmaceuticals (INO), Pfizer (PFE), Square (SQ), Aphria (APHA), Digi International (DGII) and Gilead Sciences (GILD).

Who are Vapotherm's key executives?

Vapotherm's management team includes the following people:
  • Mr. Joseph F. Army, CEO, Pres & Director (Age 55)
  • Mr. William Niland, Founder
  • Mr. John Landry, VP, CFO, Sec. & Treasurer (Age 47)
  • Mr. John Coolidge, VP of Operations (Age 58)
  • Mr. Anthony Ten Haagen, VP of Legal & Compliance

When did Vapotherm IPO?

(VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

Who are Vapotherm's major shareholders?

Vapotherm's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Perceptive Advisors LLC (7.84%), BlackRock Inc. (4.73%), Wells Fargo & Company MN (2.65%), Driehaus Capital Management LLC (2.22%), ThornTree Capital Partners LP (2.11%) and State Street Corp (1.20%). Company insiders that own Vapotherm stock include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army and Michael Mcqueen. View institutional ownership trends for Vapotherm.

Which major investors are selling Vapotherm stock?

VAPO stock was sold by a variety of institutional investors in the last quarter, including Redmile Group LLC, Taylor Frigon Capital Management LLC, Perceptive Advisors LLC, Taylor Frigon Capital Management LLC, Morgan Stanley, UBS Group AG, BlackRock Inc., and Deutsche Bank AG. View insider buying and selling activity for Vapotherm.

Which major investors are buying Vapotherm stock?

VAPO stock was bought by a variety of institutional investors in the last quarter, including ThornTree Capital Partners LP, JPMorgan Chase & Co., Wells Fargo & Company MN, Aperimus Capital LLC, Driehaus Capital Management LLC, GSA Capital Partners LLP, State Street Corp, and Invesco Ltd.. Company insiders that have bought Vapotherm stock in the last two years include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army, and Michael Mcqueen. View insider buying and selling activity for Vapotherm.

How do I buy shares of Vapotherm?

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $26.63.

How big of a company is Vapotherm?

Vapotherm has a market capitalization of $567.22 million and generates $48.10 million in revenue each year. The company earns $-51,060,000.00 in net income (profit) each year or ($2.74) on an earnings per share basis. Vapotherm employs 276 workers across the globe.

What is Vapotherm's official website?

The official website for Vapotherm is www.vapotherm.com.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.